
Creatine: Is the Supplement Ready for Clinical Use?
Like endogenous creatine, supplemental creatine is converted into phosphocreatine and stored in skeletal muscle, where it plays a critical role in rapid adenosine triphosphate (ATP) replenishment. 'Supplementation helps accelerate muscle recovery by providing an available energy reserve,' explained Beatriz Leite, clinical nutritionist with a PhD in health sciences from the Federal University of São Paulo and a member of the Multiprofessional Committee of the Brazilian Society of Rheumatology, São Paulo, Brazil.
The body naturally synthesizes around 1-2 g of creatine daily, and the compound is also present in animal-derived foods. About 1 kg of red meat contains roughly 5 g of creatine — so a 200-g serving provides about 1 g. The typical supplementation dose, ranging from 3 to 5 g/d, is designed to complement both endogenous production and dietary intake to support intramuscular creatine accumulation.
Safety Profile
A recent meta-analysis of 685 clinical trials concluded that creatine supplementation is not linked to clinically significant adverse effects and is generally well tolerated — particularly at recommended doses of 3-5 g/d or 0.1 g/kg/d. 'Creatine monohydrate is essentially identical to what the body produces. It's metabolized the same way, and I see no meaningful risk of side effects. It's a very safe supplement,' said Andréa Fioretti, head of the Department of Sports and Exercise Endocrinology at the Brazilian Society of Endocrinology and Metabolism.
Concerns have lingered about creatine's potential to elevate serum creatinine levels and place strain on liver or kidney function. However, a meta-analysis indicates that creatine does not significantly alter serum creatinine. 'Creatine is excreted by the kidneys as creatinine. So when a patient supplements with creatine, the apparent rise in serum creatinine is usually a false signal — not an indicator of renal damage,' Fioretti explained.
Supporting this, a study from the University of São Paulo found that creatine supplementation actually reduced levels of cystatin C, further reinforcing the absence of renal harm.
Nonetheless, Leite advised individualized assessment. 'In patients with renal or hepatic conditions, more careful evaluation is essential. Supplementation should only be considered if there's a clear therapeutic benefit,' she noted.
Gustavo Starling Torres, MD, sports medicine physician and director at the Brazilian Society of Exercise and Sports Medicine, agreed: 'The supplementation protocol should always be individualized, taking into account therapeutic goals, patient tolerance, and overall clinical condition.'
In such cases, renal function testing may be advisable. 'If there's concern about kidney function, a creatinine test can help guide decisions,' said Fioretti. 'This ensures the supplement is used in patients who genuinely need it — those with muscle mass deficiencies.'
Michele Trindade, PhD, adjunct professor in the Department of Physical Education at the State University of Maringá in Maringá, Brazil, and vice president of the Brazilian Association of Sports Nutrition, also advised caution when considering creatine supplementation in pregnant or breastfeeding women and in children. 'They're not currently included in official recommendations because there's insufficient safety and efficacy data for pregnant individuals and fetuses. We also don't yet know how much transfers into breast milk,' she explained.
Regarding children, Trindade added that creatine is not recommended — even in cases of malnutrition. 'When treating a malnourished child, the priority is nutritional rehabilitation. Malnutrition involves more than loss of muscle mass; it includes deficiencies in total caloric intake and essential micronutrients like vitamins and minerals that regulate metabolic function.'
Uncertain Benefits in Neurologic and Muscle Disorders
Like skeletal muscle, the brain depends on the rapid ATP regeneration provided by the creatine-phosphocreatine system, raising interest in its possible neurologic benefits. A systematic review in healthy older adults suggested that 'oral creatine administration may improve short-term memory and intelligence/reasoning of healthy individuals, but its effect on other cognitive domains remains unclear, leaving questions around ideal dosing and the mechanisms underlying potential cognitive enhancement.'
Another review exploring creatine's potential in neurologic conditions noted that while early human studies — particularly in neurodegenerative diseases — are promising, more robust evidence is needed. Well-designed, long-term randomized controlled trials are essential to establish efficacy, cost-effectiveness, and safety in these populations.
Creatine has also been studied as an adjunctive therapy for conditions such as Duchenne muscular dystrophy, amyotrophic lateral sclerosis (ALS), and certain metabolic myopathies. However, the available data remain inconclusive. In the context of muscle disorders, a systematic review observed that creatine monohydrate may help reduce intracellular calcium accumulation and provide energy for muscle contraction, though the optimal dosing and magnitude of effect are still unclear.
In a study involving 107 patients with probable or confirmed ALS, daily creatine monohydrate was well tolerated and associated with a trend toward increased survival — mirroring findings from an earlier trial. However, the authors concluded that supplementation at 5 g/d did not significantly improve markers of disease progression or reduce fatigue during isometric contraction, despite anecdotal reports from participants.
Geriatric Use
Findings on creatine supplementation in older adults remain mixed. 'Evidence is very limited in this population. Few studies have demonstrated improvements in physical performance or muscle strength,' said Ivan Aprahamian, MD, PhD, internal medicine and geriatrics specialist and a member of the Brazilian Society of Geriatrics and Gerontology.
Aprahamian noted that creatine may serve as a helpful adjunct in managing sarcopenia. 'In older adults with reduced muscle mass or strength who are engaged in resistance training, creatine may support improvements in muscle health,' he explained. The recommended dosage remains 3-5 g/d, taken consistently.
In such cases, Fioretti recommended first screening for sarcopenia using the SARC-F questionnaire — which assesses autonomy and independence — alongside grip strength testing. 'If reduced strength is confirmed, further evaluation of muscle mass using bioimpedance or DEXA, followed by a physical performance assessment, is warranted,' she said.
On the basis of results, a resistance training program can be initiated in combination with creatine supplementation and appropriate carbohydrate and protein intake. 'Older adults often consume excessive carbohydrates and insufficient protein. After approximately 6 months, it's advisable to repeat assessments to monitor improvements in muscle mass and physical function,' Fioretti added.
Leite agreed: 'Creatine is not a miracle solution. It must be combined with a well-structured dietary plan.' Even in sedentary seniors, she noted, supplementation may still offer benefits. 'While it may not significantly increase muscle mass, it can help reduce the rate of muscle loss,' she explained.
For physically inactive older adults, the standard dose of 3-5 g/d is still recommended. 'This may support musculoskeletal health, though the effect on strength is modest,' said Trindade, who also cautioned that responses may vary by sex. Limited data suggest that women — who typically have higher baseline intramuscular creatine levels — may be less responsive to supplementation. 'We don't fully understand why, but it's likely related to hormonal differences.'
Established Benefits
Despite a growing number of hypotheses, robust evidence currently supports creatine supplementation primarily in the context of sports medicine. Misconceptions persist — particularly the belief that creatine directly causes muscle hypertrophy. 'In high-intensity, short-duration resistance training, where energy reserves are quickly depleted, creatine helps by rapidly replenishing ATP. This indirectly supports muscle hypertrophy,' explained Leite.
In athletic settings, creatine can be taken either before or after exercise, with comparable benefits. 'Scientific literature shows that timing matters less than consistency. Regular use is key to saturating muscle creatine stores,' said Torres.
Creatine's effect is cumulative. 'What matters is the total amount stored in muscle,' noted Trindade. 'After ingesting monohydrate, blood levels peak at around an hour, and the creatine is distributed to muscles that haven't yet reached storage capacity. Once saturated, muscles rely on these reserves.'
For fitness professionals, the benefits are often seen in practice. 'Among clients who take creatine after workouts, I've observed better lean mass gains — which is often their primary goal,' said Celina Moreno, a trainer since the 1970s who witnessed the early rise of powdered supplements in gyms.
Alexandre Pereira da Costa Filho, who works at a chain of fitness centers, takes 9 g of creatine before bed — about 0.1 g/kg/d for his 86 kg body weight. He cautioned that loading protocols involving high initial doses followed by lower maintenance levels should be guided by a professional. 'Only do this under the supervision of a nutritionist. Always consult a qualified professional before making decisions,' he advised.
For those seeking faster performance gains, Trindade recommended a loading phase: 20 g/d, divided into four doses, for 5 days, followed by a maintenance dose of 3-5 g/d.
However, this protocol may cause fluid retention and modest weight gain. 'Most people don't notice it, but it depends on whether they're exercising enough to compensate,' added Fioretti.
Quality Control
In April, Brazil's national health regulatory agency, Anvisa, published an analysis of 41 creatine supplements from 29 manufacturers. Only one product had an incorrect concentration, but 40 showed labeling discrepancies. 'Some products may contain less creatine than declared — or even contaminants, especially when unregulated,' warned Torres. He advised choosing certified products to minimize risk.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Times
11 hours ago
- New York Times
Videos From the Amazon Reveal an Unexpected Animal Friendship
Screenwriters in search of the next Timon and Pumbaa may want to look to the Amazon, where unlikely ocelot-opossum duos have been filmed hanging out together. Researchers at Cocha Cashu Biological Station in southeastern Peru set up a camera trap to study bird behavior, but they got a surprise guest appearance instead: an ocelot trailing an opossum through the jungle at night. The ocelot, a wild cat slightly larger than a house cat, and the common opossum, a marsupial, are usually predator and prey. But in this video, they moved in tandem. 'We were skeptical about what we had seen,' said Isabel Damas-Moreira, behavioral ecologist at Bielefeld University in Germany. Perhaps the ocelot was shadowing its dinner-to-be to learn about its behavior, they wondered, although that didn't explain the opossum's laid-back behavior. Then came a second clip: the same odd couple wandering back along the trail minutes later. 'Like two old friends walking home from a bar,' Dr. Damas-Moreira said. Intrigued, they contacted researchers in other parts of the Amazon who turned up three additional, nearly identical videos from different locations and years. Dr. Damas-Moreira and her colleagues then set up an experiment, which they described last month in the journal Ecosphere. They left strips of fabric infused with ocelot scent, puma scent and a control in front of camera traps. Opossums visited the ocelot scent 12 times, often lingering to rub against, sniff or bite the fabric. The puma scent attracted just one brief visit. Want all of The Times? Subscribe.


Medscape
16 hours ago
- Medscape
Creatine: Is the Supplement Ready for Clinical Use?
Popular among bodybuilders, creatine supplementation is gaining traction for its potential use beyond athletic performance. Researchers are exploring its clinical role in managing muscular and neurologic disorders, as well as its application in geriatric care. But what evidence supports these broader uses? When is creatine appropriate to recommend, at what doses, and are there contraindications? Medscape's Portuguese edition spoke with several experts to examine how creatine supplementation may benefit patients in clinical practice. Like endogenous creatine, supplemental creatine is converted into phosphocreatine and stored in skeletal muscle, where it plays a critical role in rapid adenosine triphosphate (ATP) replenishment. 'Supplementation helps accelerate muscle recovery by providing an available energy reserve,' explained Beatriz Leite, clinical nutritionist with a PhD in health sciences from the Federal University of São Paulo and a member of the Multiprofessional Committee of the Brazilian Society of Rheumatology, São Paulo, Brazil. The body naturally synthesizes around 1-2 g of creatine daily, and the compound is also present in animal-derived foods. About 1 kg of red meat contains roughly 5 g of creatine — so a 200-g serving provides about 1 g. The typical supplementation dose, ranging from 3 to 5 g/d, is designed to complement both endogenous production and dietary intake to support intramuscular creatine accumulation. Safety Profile A recent meta-analysis of 685 clinical trials concluded that creatine supplementation is not linked to clinically significant adverse effects and is generally well tolerated — particularly at recommended doses of 3-5 g/d or 0.1 g/kg/d. 'Creatine monohydrate is essentially identical to what the body produces. It's metabolized the same way, and I see no meaningful risk of side effects. It's a very safe supplement,' said Andréa Fioretti, head of the Department of Sports and Exercise Endocrinology at the Brazilian Society of Endocrinology and Metabolism. Concerns have lingered about creatine's potential to elevate serum creatinine levels and place strain on liver or kidney function. However, a meta-analysis indicates that creatine does not significantly alter serum creatinine. 'Creatine is excreted by the kidneys as creatinine. So when a patient supplements with creatine, the apparent rise in serum creatinine is usually a false signal — not an indicator of renal damage,' Fioretti explained. Supporting this, a study from the University of São Paulo found that creatine supplementation actually reduced levels of cystatin C, further reinforcing the absence of renal harm. Nonetheless, Leite advised individualized assessment. 'In patients with renal or hepatic conditions, more careful evaluation is essential. Supplementation should only be considered if there's a clear therapeutic benefit,' she noted. Gustavo Starling Torres, MD, sports medicine physician and director at the Brazilian Society of Exercise and Sports Medicine, agreed: 'The supplementation protocol should always be individualized, taking into account therapeutic goals, patient tolerance, and overall clinical condition.' In such cases, renal function testing may be advisable. 'If there's concern about kidney function, a creatinine test can help guide decisions,' said Fioretti. 'This ensures the supplement is used in patients who genuinely need it — those with muscle mass deficiencies.' Michele Trindade, PhD, adjunct professor in the Department of Physical Education at the State University of Maringá in Maringá, Brazil, and vice president of the Brazilian Association of Sports Nutrition, also advised caution when considering creatine supplementation in pregnant or breastfeeding women and in children. 'They're not currently included in official recommendations because there's insufficient safety and efficacy data for pregnant individuals and fetuses. We also don't yet know how much transfers into breast milk,' she explained. Regarding children, Trindade added that creatine is not recommended — even in cases of malnutrition. 'When treating a malnourished child, the priority is nutritional rehabilitation. Malnutrition involves more than loss of muscle mass; it includes deficiencies in total caloric intake and essential micronutrients like vitamins and minerals that regulate metabolic function.' Uncertain Benefits in Neurologic and Muscle Disorders Like skeletal muscle, the brain depends on the rapid ATP regeneration provided by the creatine-phosphocreatine system, raising interest in its possible neurologic benefits. A systematic review in healthy older adults suggested that 'oral creatine administration may improve short-term memory and intelligence/reasoning of healthy individuals, but its effect on other cognitive domains remains unclear, leaving questions around ideal dosing and the mechanisms underlying potential cognitive enhancement.' Another review exploring creatine's potential in neurologic conditions noted that while early human studies — particularly in neurodegenerative diseases — are promising, more robust evidence is needed. Well-designed, long-term randomized controlled trials are essential to establish efficacy, cost-effectiveness, and safety in these populations. Creatine has also been studied as an adjunctive therapy for conditions such as Duchenne muscular dystrophy, amyotrophic lateral sclerosis (ALS), and certain metabolic myopathies. However, the available data remain inconclusive. In the context of muscle disorders, a systematic review observed that creatine monohydrate may help reduce intracellular calcium accumulation and provide energy for muscle contraction, though the optimal dosing and magnitude of effect are still unclear. In a study involving 107 patients with probable or confirmed ALS, daily creatine monohydrate was well tolerated and associated with a trend toward increased survival — mirroring findings from an earlier trial. However, the authors concluded that supplementation at 5 g/d did not significantly improve markers of disease progression or reduce fatigue during isometric contraction, despite anecdotal reports from participants. Geriatric Use Findings on creatine supplementation in older adults remain mixed. 'Evidence is very limited in this population. Few studies have demonstrated improvements in physical performance or muscle strength,' said Ivan Aprahamian, MD, PhD, internal medicine and geriatrics specialist and a member of the Brazilian Society of Geriatrics and Gerontology. Aprahamian noted that creatine may serve as a helpful adjunct in managing sarcopenia. 'In older adults with reduced muscle mass or strength who are engaged in resistance training, creatine may support improvements in muscle health,' he explained. The recommended dosage remains 3-5 g/d, taken consistently. In such cases, Fioretti recommended first screening for sarcopenia using the SARC-F questionnaire — which assesses autonomy and independence — alongside grip strength testing. 'If reduced strength is confirmed, further evaluation of muscle mass using bioimpedance or DEXA, followed by a physical performance assessment, is warranted,' she said. On the basis of results, a resistance training program can be initiated in combination with creatine supplementation and appropriate carbohydrate and protein intake. 'Older adults often consume excessive carbohydrates and insufficient protein. After approximately 6 months, it's advisable to repeat assessments to monitor improvements in muscle mass and physical function,' Fioretti added. Leite agreed: 'Creatine is not a miracle solution. It must be combined with a well-structured dietary plan.' Even in sedentary seniors, she noted, supplementation may still offer benefits. 'While it may not significantly increase muscle mass, it can help reduce the rate of muscle loss,' she explained. For physically inactive older adults, the standard dose of 3-5 g/d is still recommended. 'This may support musculoskeletal health, though the effect on strength is modest,' said Trindade, who also cautioned that responses may vary by sex. Limited data suggest that women — who typically have higher baseline intramuscular creatine levels — may be less responsive to supplementation. 'We don't fully understand why, but it's likely related to hormonal differences.' Established Benefits Despite a growing number of hypotheses, robust evidence currently supports creatine supplementation primarily in the context of sports medicine. Misconceptions persist — particularly the belief that creatine directly causes muscle hypertrophy. 'In high-intensity, short-duration resistance training, where energy reserves are quickly depleted, creatine helps by rapidly replenishing ATP. This indirectly supports muscle hypertrophy,' explained Leite. In athletic settings, creatine can be taken either before or after exercise, with comparable benefits. 'Scientific literature shows that timing matters less than consistency. Regular use is key to saturating muscle creatine stores,' said Torres. Creatine's effect is cumulative. 'What matters is the total amount stored in muscle,' noted Trindade. 'After ingesting monohydrate, blood levels peak at around an hour, and the creatine is distributed to muscles that haven't yet reached storage capacity. Once saturated, muscles rely on these reserves.' For fitness professionals, the benefits are often seen in practice. 'Among clients who take creatine after workouts, I've observed better lean mass gains — which is often their primary goal,' said Celina Moreno, a trainer since the 1970s who witnessed the early rise of powdered supplements in gyms. Alexandre Pereira da Costa Filho, who works at a chain of fitness centers, takes 9 g of creatine before bed — about 0.1 g/kg/d for his 86 kg body weight. He cautioned that loading protocols involving high initial doses followed by lower maintenance levels should be guided by a professional. 'Only do this under the supervision of a nutritionist. Always consult a qualified professional before making decisions,' he advised. For those seeking faster performance gains, Trindade recommended a loading phase: 20 g/d, divided into four doses, for 5 days, followed by a maintenance dose of 3-5 g/d. However, this protocol may cause fluid retention and modest weight gain. 'Most people don't notice it, but it depends on whether they're exercising enough to compensate,' added Fioretti. Quality Control In April, Brazil's national health regulatory agency, Anvisa, published an analysis of 41 creatine supplements from 29 manufacturers. Only one product had an incorrect concentration, but 40 showed labeling discrepancies. 'Some products may contain less creatine than declared — or even contaminants, especially when unregulated,' warned Torres. He advised choosing certified products to minimize risk.


Medscape
19 hours ago
- Medscape
Exercise Affects PsA Risk in Patients With Psoriasis
BOGOTÁ, Colombia — While regular physical exercise is known to reduce the risk for a wide array of chronic diseases, its role in preventing psoriatic arthritis (PsA) has not been well studied. As a result, clinicians may hesitate to recommend vigorous exercise for patients with psoriasis because of concerns about potentially triggering joint inflammation in people with subclinical PsA. But at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 Annual Meeting and Trainee Symposium , Dylan McGagh, MD, a clinical research fellow in rheumatology at Oxford University, Oxford, England, presented evidence that regular exercise could in fact be preventive in this setting. People with prevalent psoriasis but no arthritis who walked more than 10,452 steps (approximately 4 miles) daily saw a 58% lower risk of developing PsA than those who walked very little, McGagh reported. Moreover, risk was reduced in a dose-dependent manner, with every 1000 steps walked daily correlating to a 10% decrease. Other measures of exercise also correlated to reduced risk, according to McGagh. 'Any moderate-to-vigorous physical activity was associated with reduced risk of PsA,' he said. For his research, McGagh and his colleagues identified 2531 people (mean age, 63 years; 52% women; 100% White) with psoriasis from the UK Biobank Accelerometry Cohort, which enrolled more than 100,000 people aged 40-65 years between 2013 and 2015. Participants used wearable accelerometers for a median of 7 days to track their movement patterns. They were then followed for up to 8 years, with health records linked. ' We were interested in people with prevalent psoriasis without PsA,' McGagh said at the conference. 'We modeled a range of exposures, including steps, peak walking cadence or walking speed, change in hazards per 1000 increase in steps,' and time spent in sedentary and active states. Higher volume and intensity of physical activity were also associated with lower risk. 'The message here is that basically any small amount of activity is beneficial' — something easily conveyed to patients, he said. 'But we need to verify this in more diverse cohorts, and there's a need to characterize physical activity profile across the [disease] continuum,' he cautioned. The findings were received with interest at a meeting intensely focused on the potential effects of diet, exercise, and body composition on the development of PsA in people with psoriasis, even outside the context of obesity, a known risk factor for PsA in patients with psoriasis. For example, the conference began with a lively debate on whether there is sufficient evidence to recommend treatment with GLP-1 agonists in certain patients who have or are at risk for PsA. Gary Macfarlane, MD, PhD, of the University of Aberdeen, Aberdeen, Scotland, an epidemiologist specializing in musculoskeletal disease who also presented at the meeting, said in an interview that he found McGagh's results encouraging. Lifestyle interventions are 'powerful' in improving health outcomes in people, he said. 'Let's get people more active. That will improve their mental health as well,' he added. McGagh was awarded a pilot grant by GRAPPA to continue his research. In an interview at the conference, he commented that this was the first study to 'really put physical activity in the driver's seat in that story of transition' from psoriasis to PsA. He also cautioned that his study cohort was comprised entirely of White individuals, an important weakness of the study, and that the participants with psoriasis were older than typical patients with psoriasis at risk for PsA. The findings need to be replicated in more representative cohorts, 'and we're working right now to do this,' McGagh said. In the meantime, he said, clinicians should consider it safe to recommend exercise to patients with psoriasis.